Latest Stock Market News

Gold hovers just below its record high, driven by safe-haven demand due to geopolitical tensions and tariff uncertainties. Investors are keenly awaiting the Federal Reserve s policy decision and remarks from Fed Chair Jerome Powell, which could influence future monetary policy.

U.S. stocks fell on Tuesday, driven by concerns ranging from President Trump s trade wars to Big Tech outlooks and geopolitical tensions. Gold surged to over $3,000 an ounce while major Wall Street indices dropped between 0.6% and 1.7%, reflecting investors fragility and economic uncertainties ahead of the Federal Reserve s upcoming policy decisions.

Super Iron Foundry s shares will debut on the BSE SME platform at a slight premium over the IPO price of Rs 108. The company raised Rs 68 crore, which will fund working capital and debt repayment. It exports to Europe and the Middle East and has a 72,000 MT annual production capacity in West Bengal, bolstered by advanced automation.

Zydus Lifesciences received final USFDA approval to manufacture Apalutamide tablets for prostate cancer, following last week s approval for Eluxadoline tablets for IBS treatment. The stock shows a hold rating with an 18% target price upside. Despite recent approvals, the shares have declined 7% year-to-date.

Gold prices continue to rise as investors treat gold as an investment. Central banks are accumulating gold. Geopolitical risks and inflation concerns drive demand. Analysts predict that gold may reach Rs 1 lakh per 10 grams in the long-term. They recommend a systematic investment approach for investors to benefit from corrections.

India attracts substantial foreign investments as a structural growth story, but to elevate its GDP growth, key reforms in land, labor, and judicial areas are essential. Managing Director of Kotak Mahindra Asset Management, Nilesh Shah, emphasizes the need for bold policy measures to achieve higher growth rates.

According to sources familiar with the matter, the Securities and Exchange Board of India has held back its green light for the much-awaited public issues so far, as share sales by these companies could have inadvertently ended up violating rules that govern unlisted companies.

Zydus Lifesciences said it has received final approval from the US health regulator to manufacture a generic version of Apalutamide tablets used in the treatment of prostate cancer

Shares in Japan and South Korea rose, while Australian equities slipped. Contracts for US stocks inched higher after benchmarks slid on Tuesday. Investors have slashed holdings of US equities by the most on record while cash levels jumped, according to Bank of America Corp.’s latest survey.

Life Insurance Corporation of India (LIC) is set to announce its decision to acquire a minor stake in a health insurance company by the end of March. Concurrently, LIC is in talks with the Reserve Bank of India about issuing long-term government bonds with maturities of up to 100 years.